Skip to Content
US Videos

Top Biotech Acquisition Candidates

2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

Mentioned: , , , , , , , , ,

Karen Andersen: I'm Karen Andersen, senior biotech analyst at Morningstar. With me today to discuss the M&A environment is biotech analyst Lauren Migliore. Thanks for joining me, Lauren.

Lauren Migliore: Good to be here, Karen.

Karen Andersen does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.